18 commercial payer policies list J9298. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
18 policies from 15 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9298 |
|---|---|---|
| Nivolumab and relatlimab-rmbw (Opdualag) for intravenous use | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Nivolumab and Relatlimab-rmbw (Opdualag) for intravenous use | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Nivolumab and relatlimab-rmbw (Opdualag) for intravenous use | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Nivolumab and Relatlimab-rmbw (Opdualag) for intravenous use | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Opdualag (nivolumab and relatlimab-rmbw) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Opdualag (nivolumab and relatlimabrmbw) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Nivolumab and relatlimab-rmbw (e.g., Opdualag) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9298 |
|---|---|---|
| OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Nivolumab/Relatlimab-rmbw (Opdualag) | Jun 30, 2022 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Nivolumab; Relatlimab-rmbw (Opdualag) injection | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Nivolumab/Relatlimab-rmbw (Opdualag); CP.PHAR.588 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9298 |
|---|---|---|
| Opdualag (nivolumab/relatlimab-rmbw) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |